Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

How is the process of setting micronutrients recommendations reflected in nutrition policies in Poland? The case study of folate.

Sicińska E, Jeruszka-Bielak M, Roszkowski W, Brzozowska A, Jarosz M, Raats MM.

Ann Agric Environ Med. 2018 Mar 14;25(1):82-86. doi: 10.5604/12321966.1230670. Epub 2016 Dec 28.

2.

Kinase-independent function of E-type cyclins in liver cancer.

Geng Y, Michowski W, Chick JM, Wang YE, Jecrois ME, Sweeney KE, Liu L, Han RC, Ke N, Zagozdzon A, Sicinska E, Bronson RT, Gygi SP, Sicinski P.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1015-1020. doi: 10.1073/pnas.1711477115. Epub 2018 Jan 16.

PMID:
29339491
3.

Corrigendum: In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.

Roper J, Tammela T, Cetinbas NM, Akkad A, Roghanian A, Rickelt S, Almeqdadi M, Wu K, Oberli MA, Sánchez-Rivera F, Park YK, Liang X, Eng G, Taylor MS, Azimi R, Kedrin D, Neupane R, Beyaz S, Sicinska ET, Suarez Y, Yoo J, Chen L, Zukerberg L, Katajisto P, Deshpande V, Bass AJ, Tsichlis PN, Lees J, Langer R, Hynes RO, Chen J, Bhutkar A, Jacks T, Yilmaz ÖH.

Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211a.

PMID:
29220013
4.

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.

Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, Élez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M.

Science. 2017 Dec 15;358(6369):1443-1448. doi: 10.1126/science.aal5240. Epub 2017 Nov 23.

PMID:
29170280
5.

Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit.

Otto T, Candido SV, Pilarz MS, Sicinska E, Bronson RT, Bowden M, Lachowicz IA, Mulry K, Fassl A, Han RC, Jecrois ES, Sicinski P.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10660-10665. doi: 10.1073/pnas.1702914114. Epub 2017 Sep 18.

6.

Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.

Bowden M, Zhou CW, Zhang S, Brais L, Rossi A, Naudin L, Thiagalingam A, Sicinska E, Kulke MH.

Oncotarget. 2017 Apr 7;8(33):54331-54344. doi: 10.18632/oncotarget.16908. eCollection 2017 Aug 15.

7.

The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.

Wang H, Nicolay BN, Chick JM, Gao X, Geng Y, Ren H, Gao H, Yang G, Williams JA, Suski JM, Keibler MA, Sicinska E, Gerdemann U, Haining WN, Roberts TM, Polyak K, Gygi SP, Dyson NJ, Sicinski P.

Nature. 2017 Jun 15;546(7658):426-430. doi: 10.1038/nature22797. Epub 2017 Jun 7.

8.

Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces serum homocysteine concentrations in older adults.

Sicińska E, Brzozowska A, Roszkowski W, Finglas PM.

Int J Food Sci Nutr. 2018 Feb;69(1):64-73. doi: 10.1080/09637486.2017.1320536. Epub 2017 May 2.

PMID:
28460586
9.

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.

Roper J, Tammela T, Cetinbas NM, Akkad A, Roghanian A, Rickelt S, Almeqdadi M, Wu K, Oberli MA, Sánchez-Rivera FJ, Park YK, Liang X, Eng G, Taylor MS, Azimi R, Kedrin D, Neupane R, Beyaz S, Sicinska ET, Suarez Y, Yoo J, Chen L, Zukerberg L, Katajisto P, Deshpande V, Bass AJ, Tsichlis PN, Lees J, Langer R, Hynes RO, Chen J, Bhutkar A, Jacks T, Yilmaz ÖH.

Nat Biotechnol. 2017 Jun;35(6):569-576. doi: 10.1038/nbt.3836. Epub 2017 May 1. Erratum in: Nat Biotechnol. 2017 Dec 8;35(12 ):1211.

10.

Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.

Hydbring P, Wang Y, Fassl A, Li X, Matia V, Otto T, Choi YJ, Sweeney KE, Suski JM, Yin H, Bogorad RL, Goel S, Yuzugullu H, Kauffman KJ, Yang J, Jin C, Li Y, Floris D, Swanson R, Ng K, Sicinska E, Anders L, Zhao JJ, Polyak K, Anderson DG, Li C, Sicinski P.

Cancer Cell. 2017 Apr 10;31(4):576-590.e8. doi: 10.1016/j.ccell.2017.03.004.

11.

MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation.

Schaefer IM, Wang Y, Liang CW, Bahri N, Quattrone A, Doyle L, Mariño-Enríquez A, Lauria A, Zhu M, Debiec-Rychter M, Grunewald S, Hechtman JF, Dufresne A, Antonescu CR, Beadling C, Sicinska ET, van de Rijn M, Demetri GD, Ladanyi M, Corless CL, Heinrich MC, Raut CP, Bauer S, Fletcher JA.

Nat Commun. 2017 Mar 8;8:14674. doi: 10.1038/ncomms14674.

12.

ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.

Wang B, Krall EB, Aguirre AJ, Kim M, Widlund HR, Doshi MB, Sicinska E, Sulahian R, Goodale A, Cowley GS, Piccioni F, Doench JG, Root DE, Hahn WC.

Cell Rep. 2017 Feb 7;18(6):1543-1557. doi: 10.1016/j.celrep.2017.01.031.

13.

CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma.

Zhou J, Wu Z, Wong G, Pectasides E, Nagaraja A, Stachler M, Zhang H, Chen T, Zhang H, Liu JB, Xu X, Sicinska E, Sanchez-Vega F, Rustgi AK, Diehl JA, Wong KK, Bass AJ.

Nat Commun. 2017 Jan 6;8:13897. doi: 10.1038/ncomms13897.

14.

Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma.

Nakayama R, Zhang YX, Czaplinski JT, Anatone AJ, Sicinska ET, Fletcher JA, Demetri GD, Wagner AJ.

Oncotarget. 2016 Mar 29;7(13):16581-92. doi: 10.18632/oncotarget.7667.

15.

Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.

Derks S, Nason KS, Liao X, Stachler MD, Liu KX, Liu JB, Sicinska E, Goldberg MS, Freeman GJ, Rodig SJ, Davison JM, Bass AJ.

Cancer Immunol Res. 2015 Oct;3(10):1123-1129. doi: 10.1158/2326-6066.CIR-15-0046. Epub 2015 Jun 16.

16.

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.

Eilers G, Czaplinski JT, Mayeda M, Bahri N, Tao D, Zhu M, Hornick JL, Lindeman NI, Sicinska E, Wagner AJ, Fletcher JA, Mariño-Enriquez A.

Mol Cancer Ther. 2015 Jun;14(6):1346-53. doi: 10.1158/1535-7163.MCT-14-0793. Epub 2015 Apr 7.

17.

Communication of scientific uncertainty: international case studies on the development of folate and vitamin D Dietary Reference Values.

Brown KA, de Wit L, Timotijevic L, Sonne AM, Lähteenmäki L, Brito Garcia N, Jeruszka-Bielak M, Sicińska E, Moore AN, Lawrence M, Raats MM.

Public Health Nutr. 2015 Jun;18(8):1378-88. doi: 10.1017/S1368980014002006. Epub 2014 Sep 23.

PMID:
25246004
18.

Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.

Zhang YX, Sicinska E, Czaplinski JT, Remillard SP, Moss S, Wang Y, Brain C, Loo A, Snyder EL, Demetri GD, Kim S, Kung AL, Wagner AJ.

Mol Cancer Ther. 2014 Sep;13(9):2184-93. doi: 10.1158/1535-7163.MCT-14-0387. Epub 2014 Jul 15.

19.

c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.

Sioletic S, Czaplinski J, Hu L, Fletcher JA, Fletcher CD, Wagner AJ, Loda M, Demetri GD, Sicinska ET, Snyder EL.

J Pathol. 2014 Oct;234(2):190-202. doi: 10.1002/path.4379. Epub 2014 Aug 1.

20.

A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.

Zadra G, Photopoulos C, Tyekucheva S, Heidari P, Weng QP, Fedele G, Liu H, Scaglia N, Priolo C, Sicinska E, Mahmood U, Signoretti S, Birnberg N, Loda M.

EMBO Mol Med. 2014 Apr;6(4):519-38. doi: 10.1002/emmm.201302734. Epub 2014 Feb 4. Erratum in: EMBO Mol Med. 2014 Oct;6(10):1357.

21.

EURRECA-A framework for considering evidence in public health nutrition policy development.

Timotijevic L, Brown KA, Lähteenmäki L, de Wit L, Sonne AM, Ruprich J, Rehůřková I, Jeruszka-Bielak M, Sicinska E, Brito García N, Guzzon A, Jensen BB, Shepherd R, Barnett J, Raats MM.

Crit Rev Food Sci Nutr. 2013;53(10):1124-34. doi: 10.1080/10408398.2012.747485. Review.

PMID:
23952092
22.

Intakes of folic acid from dietary supplements and fortified products in students.

Sicińska E, Bojarska K.

Rocz Panstw Zakl Hig. 2013;64(1):55-9.

23.

Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy.

Zhang YX, van Oosterwijk JG, Sicinska E, Moss S, Remillard SP, van Wezel T, Bühnemann C, Hassan AB, Demetri GD, Bovée JV, Wagner AJ.

Clin Cancer Res. 2013 Jul 15;19(14):3796-807. doi: 10.1158/1078-0432.CCR-12-3647. Epub 2013 May 28.

24.

Genome-wide functional screening identifies CDC37 as a crucial HSP90-cofactor for KIT oncogenic expression in gastrointestinal stromal tumors.

Mariño-Enríquez A, Ou WB, Cowley G, Luo B, Jonker AH, Mayeda M, Okamoto M, Eilers G, Czaplinski JT, Sicinska E, Wang Y, Taguchi T, Demetri GD, Root DE, Fletcher JA.

Oncogene. 2014 Apr 3;33(14):1872-6. doi: 10.1038/onc.2013.127. Epub 2013 Apr 15.

25.

A survey of foodstuffs fortified with vitamins available on the market in Warsaw.

Sicińska E, Jeruszka-Bielak M, Masalska K, Wronowski S.

Rocz Panstw Zakl Hig. 2013;64(4):293-8.

26.

[Influence of selected factors on fortified food intake by children].

Rolf K, Januszko O, Bylinowska J, Sicińska E, Pietruszka B, Kałuza J.

Rocz Panstw Zakl Hig. 2012;63(3):339-46. Polish.

27.

Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number.

Sankaran VG, Ludwig LS, Sicinska E, Xu J, Bauer DE, Eng JC, Patterson HC, Metcalf RA, Natkunam Y, Orkin SH, Sicinski P, Lander ES, Lodish HF.

Genes Dev. 2012 Sep 15;26(18):2075-87. doi: 10.1101/gad.197020.112. Epub 2012 Aug 28.

28.

[Evaluation of the needs and possibilities of increasing the vitamin B12 content in diet].

Sicińska E, Cholewa M.

Rocz Panstw Zakl Hig. 2012;63(1):67-71. Polish.

29.

[Factors influenced vitamin or mineral supplements use in a chosen group of children aged 6-12].

Bylinowska J, Januszko O, Rolf K, Sicińska E, Kałuza J, Pietruszka B.

Rocz Panstw Zakl Hig. 2012;63(1):59-66. Polish.

30.

[Folate intake in Poland on the basis of literature from the last ten years (2000-2010)].

Sicińska E, Wyka J.

Rocz Panstw Zakl Hig. 2011;62(3):247-56. Review. Polish.

31.

[Fortified food products as a potential source of folic acid in human nutrition].

Sicińska E, Pelc A.

Rocz Panstw Zakl Hig. 2011;62(2):209-14. Polish.

32.

Aberrant AKT activation drives well-differentiated liposarcoma.

Gutierrez A, Snyder EL, Marino-Enriquez A, Zhang YX, Sioletic S, Kozakewich E, Grebliunaite R, Ou WB, Sicinska E, Raut CP, Demetri GD, Perez-Atayde AR, Wagner AJ, Fletcher JA, Fletcher CD, Look AT.

Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16386-91. doi: 10.1073/pnas.1106127108. Epub 2011 Sep 19.

33.

Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.

Priolo C, Agostini M, Vena N, Ligon AH, Fiorentino M, Shin E, Farsetti A, Pontecorvi A, Sicinska E, Loda M.

Am J Pathol. 2010 Apr;176(4):1901-13. doi: 10.2353/ajpath.2010.090873. Epub 2010 Feb 18.

34.

c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.

Snyder EL, Sandstrom DJ, Law K, Fiore C, Sicinska E, Brito J, Bailey D, Fletcher JA, Loda M, Rodig SJ, Dal Cin P, Fletcher CD.

J Pathol. 2009 Jul;218(3):292-300. doi: 10.1002/path.2564.

PMID:
19449367
35.

DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.

Wang F, Wang L, Briggs C, Sicinska E, Gaston SM, Mamon H, Kulke MH, Zamponi R, Loda M, Maher E, Ogino S, Fuchs CS, Li J, Hader C, Makrigiorgos GM.

J Mol Diagn. 2007 Sep;9(4):441-51. Epub 2007 Aug 9.

36.

Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes.

Sicinska E, Lee YM, Gits J, Shigematsu H, Yu Q, Rebel VI, Geng Y, Marshall CJ, Akashi K, Dorfman DM, Touw IP, Sicinski P.

Mol Cell Biol. 2006 Nov;26(21):8052-60. Epub 2006 Sep 5.

37.

The isopeptidase USP2a protects human prostate cancer from apoptosis.

Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M.

Cancer Res. 2006 Sep 1;66(17):8625-32.

38.

Androgen-dependent regulation of Her-2/neu in prostate cancer cells.

Berger R, Lin DI, Nieto M, Sicinska E, Garraway LA, Adams H, Signoretti S, Hahn WC, Loda M.

Cancer Res. 2006 Jun 1;66(11):5723-8.

39.

A unique function for cyclin D3 in early B cell development.

Cooper AB, Sawai CM, Sicinska E, Powers SE, Sicinski P, Clark MR, Aifantis I.

Nat Immunol. 2006 May;7(5):489-97. Epub 2006 Apr 2.

PMID:
16582912
40.

Requirement for CDK4 kinase function in breast cancer.

Yu Q, Sicinska E, Geng Y, Ahnström M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, Stål O, Sicinski P.

Cancer Cell. 2006 Jan;9(1):23-32.

41.

Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth.

Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF.

Mol Cell Biol. 2005 May;25(9):3752-62.

42.

[Role of folates in the nutrition of the elderly].

Brzozowska A, Sicińska E, Roszkowski W.

Rocz Panstw Zakl Hig. 2004;55(2):159-64. Review. Polish.

PMID:
15493348
43.

Mouse development and cell proliferation in the absence of D-cyclins.

Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson RT, Akashi K, Sicinski P.

Cell. 2004 Aug 20;118(4):477-91.

44.

Requirement for cyclin D3 in lymphocyte development and T cell leukemias.

Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, Yu Q, Ferrando AA, Levin SD, Geng Y, von Boehmer H, Sicinski P.

Cancer Cell. 2003 Dec;4(6):451-61.

45.

Cyclin E ablation in the mouse.

Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P.

Cell. 2003 Aug 22;114(4):431-43.

46.

[Health status of people aged 75-80 living in Warsaw and its regions].

Sicińska E, Kałuza J, Brzozowska A, Roszkowski W.

Rocz Panstw Zakl Hig. 2003;54(1):97-107. Polish.

PMID:
12870302
47.

Development of mice expressing a single D-type cyclin.

Ciemerych MA, Kenney AM, Sicinska E, Kalaszczynska I, Bronson RT, Rowitch DH, Gardner H, Sicinski P.

Genes Dev. 2002 Dec 15;16(24):3277-89.

48.

Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.

Jena N, Deng M, Sicinska E, Sicinski P, Daley GQ.

Cancer Res. 2002 Jan 15;62(2):535-41.

49.

Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice.

Geng Y, Yu Q, Sicinska E, Das M, Bronson RT, Sicinski P.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):194-9.

50.

Preanalytical variables affecting the quantification of fatty acid ethyl esters in plasma and serum samples.

Soderberg BL, Sicinska ET, Blodget E, Cluette-Brown JE, Suter PM, Schuppisser T, Vetter W, Laposata M.

Clin Chem. 1999 Dec;45(12):2183-90.

Supplemental Content

Loading ...
Support Center